 |
市场调查报告书
商品编码
1555526
生殖器疱疹市场，按类型、管理途径、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测Genital Herpes Market, By Type, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032 |
||||||
报告要点
2023年，生殖器疱疹市场规模为9.8767亿美元，2024年至2032年复合年增长率为4.89%。
生殖器疱疹市场-市场动态
生殖器疱疹患病率的增加预计将推动市场的成长
生殖器疱疹是全球最受欢迎的性传染病 (STI) 之一。这种疾病发生率的增加对市场产生了各种影响，影响了对诊断服务的需求和有效治疗替代方案的必要性。据世界卫生组织称，全球约有 37 亿 50 岁以下的人 (67%) 感染 1 型单纯疱疹病毒 (HSV-1)，该病毒主要引起口腔疱疹。此外，估计全球有 4.91 亿 15 至 49 岁的人 (13%) 受到 2 型单纯疱疹病毒 (HSV-2) 的影响，这是生殖器疱疹的主要原因。此外，正在进行的单纯疱疹病毒疫苗研究为市场成长提供了相当大的机会。然而，高昂的治疗成本可能会对市场的扩张构成挑战。
生殖器疱疹市场 - 主要见解
根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 4.89% 左右的复合年增长率成长
根据给药途径细分，预计 Oral 将在 2023 年显示最大的市场份额
根据最终用户细分，零售药局是 2023 年的主导类型
按地区划分，北美是 2023 年的主要收入来源
生殖器疱疹市场-細項分析：
全球生殖器疱疹市场根据类型、给药途径、最终用户和地区进行细分。
市场根据类型分为两个部分：诊断和治疗。随着持续的研究和意识的提高，诊断和治疗市场预计将成长，为患者和医疗保健专业人员提供改进的解决方案。
根据给药途径，市场分为三个部分：口服、注射和外用。口服药物因其係统有效性和使用方便而引领市场，而局部治疗则提供有针对性的缓解。注射药物虽然不太流行，但在治疗严重疾病方面发挥着至关重要的作用。
根据最终用户，市场分为两个主要类别：医院药房、零售药房、线上药房和其他。零售药局在市场上占据主导地位。他们在生殖器疱疹领域发挥着重要作用，提供处方和非处方治疗、促进患者教育和加强医疗保健服务。
生殖器疱疹市场 - 地理洞察
该市场地域广泛，涵盖北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些领域根据对商业活动做出贡献的国家进一步分类。北美在市场成长方面处于领先地位，这主要是由于同性恋者对生殖器疱疹治疗的需求不断增长。该地区生殖器疱疹发病率很高，相当一部分人口受到 HSV-1 和 HSV-2 的影响。这种盛行率的升高强调了彻底的诊断和治疗选择的必要性。美国食品药物管理局 (FDA) 在新疗法的批准和监管方面发挥重要作用，确保市场上提供有效和安全的药物。根据美国国家医学图书馆的数据，美国每 1,000 名新生儿中就有 1 人被诊断出患有新生儿疱疹感染，如果母亲在怀孕期间感染生殖器 HSV 并将其传染给胎儿，则风险会增加。由于生殖器疱疹的高盛行率和认识，欧洲成为市场成长的第二大地区。
生殖器疱疹市场-竞争格局：
生殖器疱疹市场呈现出竞争激烈的环境，其特点是有许多参与者从事诊断测试和治疗方案的开发、生产和分销。製造商正在优先考虑旨在创建更精确、更快速的诊断测试的投资。此外，他们正在扩大新市场和地区的影响力，以提高产品的可及性。製药公司、诊断测试製造商和零售药局都为提供生殖器疱疹治疗和诊断做出了重大贡献。
最新进展：
2023年11月，雅培实验室的分子人类乳突病毒（HPV）筛检测试获得美国食品药物管理局的批准，从而增强了该公司的癌症筛检仪器产品组合。 Alinity M 系列诊断检测的最新成员适用于根据现有指南进行筛检以及诊断目的，并提供对可能导致癌症的病毒基因型的全面了解。
2024 年 3 月，太阳製药工业公司 (Sun Pharmaceutical Industries Inc.) 宣布召回 47,520 瓶 40 毫克药物和 7,488 瓶 80 毫克製剂，理由是不符合现行良好生产规范 (CGMP) 法规。
目录
第一章：生殖器疱疹市场概述
- 研究范围
- 市场预估年份
第 2 章：执行摘要
- 市场片段
- 按类型分類的生殖器疱疹市场片段
- 依给药途径分類的生殖器疱疹市场片段
- 最终用户的生殖器疱疹市场片段
- 按国家/地区分類的生殖器疱疹市场片段
- 按地区分類的生殖器疱疹市场片段
- 竞争洞察
第 3 章：生殖器疱疹主要市场趋势
- 生殖器疱疹市场驱动因素
- 市场驱动因素的影响分析
- 生殖器疱疹市场限制
- 市场限制影响分析
- 生殖器疱疹市场机会
- 生殖器疱疹市场未来趋势
第 4 章：生殖器疱疹产业研究
- PEST分析
- 波特五力分析
- 成长前景图
- 规范架构分析
第 5 章：生殖器疱疹市场：COVID-19 影响分析
- COVID-19 之前的影响分析
- COVID-19 后影响分析
- 表现最佳的市场区隔
- 边际增长部分
- 最鬆散的部分
- 边际损失部分
第 6 章：生殖器疱疹市场格局
- 2023 年生殖器疱疹市场占有率分析
- 按主要製造商分類的故障数据
- 既定玩家分析
- 新兴玩家分析
第 7 章：生殖器疱疹市场 - 按类型
- 概述
- 按类型分類的细分市场占有率分析
- 诊断
- 治疗
- 阿昔洛韦
- 泛昔洛韦
- 伐昔洛韦
- 其他的
第 8 章：生殖器疱疹市场 - 按给药途径
- 概述
- 按给药途径分類的细分市场份额分析
- 口服
- 可注射
- 专题
第 9 章：生殖器疱疹市场 - 按最终用户
- 概述
- 按最终用户分類的细分市场占有率分析
- 医院药房
- 零售药局
- 网路药局
- 其他的
第 10 章：生殖器疱疹市场 - 按地理位置
- 介绍
- 按地理位置分類的细分市场占有率分析
- 北美洲
- 概述
- 北美生殖器疱疹主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按类型）
- 北美市场规模与预测（按管理途径）
- 北美市场规模和预测（按最终用户）
- 我们
- 加拿大
- 欧洲
- 概述
- 欧洲生殖器疱疹主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按类型）
- 欧洲市场规模与预测（按管理途径）
- 欧洲市场规模和预测（按最终用户）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
- 亚太地区 (APAC)
- 概述
- 亚太地区生殖器疱疹主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按类型）
- 亚太地区市场规模与预测（依管理途径）
- 亚太地区市场规模和预测（按最终用户）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
- 拉丁美洲
- 概述
- 拉丁美洲生殖器疱疹主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按类型）
- 拉丁美洲市场规模与预测（按管理途径）
- 拉丁美洲市场规模和预测（按最终用户）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
- 中东和非洲
- 概述
- 中东和非洲生殖器疱疹主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按类型）
- 中东和非洲市场规模及预测（按管理途径）
- 中东和非洲市场规模和预测（按最终用户）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分
第 11 章：主要供应商分析 - 生殖器疱疹产业
- 竞争仪表板
- 公司简介
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- Sun Pharmaceuticals Industries Ltd.
- Mylan NV
- Pfizer Inc.
- GlaxoSmithKline plc
- Dr. Reddy's Laboratories, ltd.
- Novartis AG
- Valeant Pharmaceuticals International Inc. etc.
- Others
第 12 章：360 度分析师视角
第 13 章：附录
- 研究方法
- 参考
- 缩写
- 免责声明
- 联络我们
REPORT HIGHLIGHT
Genital Herpes Market size was valued at USD 987.67 Million in 2023, expanding at a CAGR of 4.89% from 2024 to 2032.
Genital herpes is a prevalent sexually transmitted infection (STI) resulting from the herpes simplex virus (HSV). This condition is marked by recurring episodes of painful sores and blisters in the genital and anal regions. The two types of herpes simplex virus responsible for genital herpes are HSV-1 and HSV-2. According to the World Health Organization, approximately 3.7 billion individuals under the age of 50 were infected with HSV-1 in 2016. Additionally, around 491 million people aged 15 to 49 were reported to have an HSV-2 infection in the same year.
Genital Herpes Market- Market Dynamics
The increasing prevalence of genital herpes is projected to drive the growth of the market
Genital herpes ranks among the most prevalent sexually transmitted infections (STIs) across the globe. The increasing incidence of this condition carries various implications for the market, affecting both the demand for diagnostic services and the necessity for effective treatment alternatives. According to the World Health Organization, approximately 3.7 billion individuals under the age of 50 (67%) worldwide are infected with herpes simplex virus type 1 (HSV-1), which primarily causes oral herpes. Additionally, an estimated 491 million people aged 15 to 49 (13%) globally are affected by herpes simplex virus type 2 (HSV-2), the primary cause of genital herpes. Moreover, ongoing investigations into vaccines for the herpes simplex virus offer a considerable opportunity for market growth. Nevertheless, the high cost of treatment may pose a challenge to the expansion of the market.
Genital Herpes Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.89% over the forecast period (2024-2032)
Based on the Route of administration segmentation, Oral was predicted to show maximum market share in the year 2023
Based on End-User segmentation, Retail Pharmacies were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
Genital Herpes Market- Segmentation Analysis:
The Global Genital Herpes Market is segmented based on Type, Route of Administration, End-User, and Region.
The market is classified into two segments according to Type: Diagnosis and Treatment. With ongoing research and heightened awareness, the market for both diagnosis and treatment is anticipated to grow, providing improved solutions for patients and healthcare professionals.
The market is classified into three segments according to the Route of Administration: Oral, Injectable, and Topical. Oral medications lead the market owing to their systemic effectiveness and convenience of use, whereas topical treatments offer targeted relief. Injectable medications, although less prevalent, play a crucial role in managing severe conditions.
The market is segmented into two primary categories according to End-User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. Retail Pharmacies hold a dominant position within the market. They play an essential role in the genital herpes sector by providing access to both prescription and over-the-counter treatments, facilitating patient education, and enhancing healthcare delivery.
Genital Herpes Market- Geographical Insights
This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further categorized based on the countries contributing to business activities. North America leads in market growth, primarily driven by the rising demand for genital herpes treatments among homosexual individuals. The region exhibits a significant prevalence of genital herpes, with a considerable segment of the population affected by HSV-1 and HSV-2. This elevated prevalence underscores the need for thorough diagnostic and treatment options. The U.S. Food and Drug Administration (FDA) is instrumental in the approval and regulation of new therapies, ensuring the availability of effective and safe medications in the marketplace. According to the National Library of Medicine, 1 in 1,000 newborns in the United States is diagnosed with neonatal herpes infection, with the risk increasing if the mother contracts genital HSV infection during pregnancy and transmits it to the fetus. Europe ranks as the second-largest region for market growth, attributed to the high prevalence and awareness of genital herpes.
Genital Herpes Market- Competitive Landscape:
The genital herpes market exhibits a competitive environment, characterized by numerous participants engaged in the development, production, and distribution of diagnostic tests and therapeutic options. Manufacturers are prioritizing investments aimed at creating more precise and rapid diagnostic tests. Additionally, they are broadening their reach into new markets and regions to enhance product accessibility. Pharmaceutical firms, diagnostic test manufacturers, and retail pharmacies each contribute significantly to the provision of treatments and diagnostics for genital herpes.
Recent Developments:
In November 2023, Abbott Laboratories obtained approval from the U.S. Food and Drug Administration for its molecular human papillomavirus (HPV) screening test, thereby enhancing the company's portfolio of cancer screening instruments. This latest addition to the Alinity M series of diagnostic assays is suitable for screening by existing guidelines, as well as for diagnostic purposes, and offers comprehensive insights into the genotypes of the virus that may lead to cancer.
In March 2024, Sun Pharmaceutical Industries Inc. announced the recall of 47,520 bottles of the 40 mg medication and 7,488 bottles of the 80 mg formulation, citing deviations from Current Good Manufacturing Practice (CGMP) regulations.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENITAL HERPES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- Sun Pharmaceuticals Industries Ltd.
- Mylan N.V.
- Pfizer Inc.
- GlaxoSmithKline plc
- Dr. Reddy's Laboratories, ltd.
- Novartis AG
- Valeant Pharmaceuticals International Inc. etc.
- Others
GLOBAL GENITAL HERPES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Diagnosis
- Treatment
- Acyclovir
- Famciclovir
- Valacyclovir
- Others
GLOBAL GENITAL HERPES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
- Oral
- Injectable
- Topical
GLOBAL GENITAL HERPES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
GLOBAL GENITAL HERPES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Genital Herpes Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Genital Herpes Market Snippet by Type
- 2.1.2. Genital Herpes Market Snippet by Route of Administration
- 2.1.3. Genital Herpes Market Snippet by End-User
- 2.1.4. Genital Herpes Market Snippet by Country
- 2.1.5. Genital Herpes Market Snippet by Region
- 2.2. Competitive Insights
3. Genital Herpes Key Market Trends
- 3.1. Genital Herpes Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Genital Herpes Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Genital Herpes Market Opportunities
- 3.4. Genital Herpes Market Future Trends
4. Genital Herpes Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Genital Herpes Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Genital Herpes Market Landscape
- 6.1. Genital Herpes Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Genital Herpes Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Diagnosis
- 7.1.3. Treatment
- 7.1.3.1. Acyclovir
- 7.1.3.2. Famciclovir
- 7.1.3.3. Valacyclovir
- 7.1.3.4. Others
8. Genital Herpes Market - By Route of Administration
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
- 8.1.2. Oral
- 8.1.3. Injectable
- 8.1.4. Topical
9. Genital Herpes Market - By End-User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Online Pharmacies
- 9.1.5. Others
10. Genital Herpes Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Genital Herpes Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Genital Herpes Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Genital Herpes Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Genital Herpes Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Genital Herpes Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Genital Herpes Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Teva Pharmaceutical Industries Ltd.
- 11.2.2. Abbott Laboratories
- 11.2.3. Sun Pharmaceuticals Industries Ltd.
- 11.2.4. Mylan N.V.
- 11.2.5. Pfizer Inc.
- 11.2.6. GlaxoSmithKline plc
- 11.2.7. Dr. Reddy's Laboratories, ltd.
- 11.2.8. Novartis AG
- 11.2.9. Valeant Pharmaceuticals International Inc. etc.
- 11.2.10. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
